These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 20858963)

  • 1. EEG, activity, and sleep architecture in a transgenic AβPPswe/PSEN1A246E Alzheimer's disease mouse.
    Jyoti A; Plano A; Riedel G; Platt B
    J Alzheimers Dis; 2010; 22(3):873-87. PubMed ID: 20858963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sleep and EEG Power Spectral Analysis in Three Transgenic Mouse Models of Alzheimer's Disease: APP/PS1, 3xTgAD, and Tg2576.
    Kent BA; Strittmatter SM; Nygaard HB
    J Alzheimers Dis; 2018; 64(4):1325-1336. PubMed ID: 29991134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of aging and genotype on circadian rhythms, sleep, and clock gene expression in APPxPS1 knock-in mice, a model for Alzheimer's disease.
    Duncan MJ; Smith JT; Franklin KM; Beckett TL; Murphy MP; St Clair DK; Donohue KD; Striz M; O'Hara BF
    Exp Neurol; 2012 Aug; 236(2):249-58. PubMed ID: 22634208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presenilin-1 but not amyloid precursor protein mutations present in mouse models of Alzheimer's disease attenuate the response of cultured cells to γ-secretase modulators regardless of their potency and structure.
    Hahn S; Brüning T; Ness J; Czirr E; Baches S; Gijsen H; Korth C; Pietrzik CU; Bulic B; Weggen S
    J Neurochem; 2011 Feb; 116(3):385-95. PubMed ID: 21091478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circadian system functionality, hippocampal oxidative stress, and spatial memory in the APPswe/PS1dE9 transgenic model of Alzheimer disease: effects of melatonin or ramelteon.
    Baño Otalora B; Popovic N; Gambini J; Popovic M; Viña J; Bonet-Costa V; Reiter RJ; Camello PJ; Rol MÁ; Madrid JA
    Chronobiol Int; 2012 Aug; 29(7):822-34. PubMed ID: 22823866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sleep and circadian abnormalities in a transgenic mouse model of Alzheimer's disease: a role for cholinergic transmission.
    Wisor JP; Edgar DM; Yesavage J; Ryan HS; McCormick CM; Lapustea N; Murphy GM
    Neuroscience; 2005; 131(2):375-85. PubMed ID: 15708480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-cognitive behaviours in an APP/PS1 transgenic model of Alzheimer's disease.
    Pugh PL; Richardson JC; Bate ST; Upton N; Sunter D
    Behav Brain Res; 2007 Mar; 178(1):18-28. PubMed ID: 17229472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calretinin interneurons are early targets of extracellular amyloid-beta pathology in PS1/AbetaPP Alzheimer mice hippocampus.
    Baglietto-Vargas D; Moreno-Gonzalez I; Sanchez-Varo R; Jimenez S; Trujillo-Estrada L; Sanchez-Mejias E; Torres M; Romero-Acebal M; Ruano D; Vizuete M; Vitorica J; Gutierrez A
    J Alzheimers Dis; 2010; 21(1):119-32. PubMed ID: 20413859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral and EEG changes in male 5xFAD mice.
    Schneider F; Baldauf K; Wetzel W; Reymann KG
    Physiol Behav; 2014 Aug; 135():25-33. PubMed ID: 24907698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice.
    Dragicevic N; Mamcarz M; Zhu Y; Buzzeo R; Tan J; Arendash GW; Bradshaw PC
    J Alzheimers Dis; 2010; 20 Suppl 2():S535-50. PubMed ID: 20463404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. D-Ala2GIP facilitated synaptic plasticity and reduces plaque load in aged wild type mice and in an Alzheimer's disease mouse model.
    Faivre E; Hölscher C
    J Alzheimers Dis; 2013; 35(2):267-83. PubMed ID: 23568101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the 3xTg-AD mouse model of Alzheimer's disease: part 1. Circadian changes.
    Sterniczuk R; Dyck RH; Laferla FM; Antle MC
    Brain Res; 2010 Aug; 1348():139-48. PubMed ID: 20471965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The GABAA receptor agonist THIP alters the EEG in waking and sleep of mice.
    Vyazovskiy VV; Kopp C; Bösch G; Tobler I
    Neuropharmacology; 2005 Apr; 48(5):617-26. PubMed ID: 15814097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lesion-induced hippocampal plasticity in transgenic Alzheimer's disease mouse models: influences of age, genotype, and estrogen.
    Kadish I; van Groen T
    J Alzheimers Dis; 2009; 18(2):429-45. PubMed ID: 19584452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities.
    Savonenko A; Xu GM; Melnikova T; Morton JL; Gonzales V; Wong MP; Price DL; Tang F; Markowska AL; Borchelt DR
    Neurobiol Dis; 2005 Apr; 18(3):602-17. PubMed ID: 15755686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The EEG effects of THIP (Gaboxadol) on sleep and waking are mediated by the GABA(A)delta-subunit-containing receptors.
    Winsky-Sommerer R; Vyazovskiy VV; Homanics GE; Tobler I
    Eur J Neurosci; 2007 Mar; 25(6):1893-9. PubMed ID: 17408425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Grape seed polyphenols and curcumin reduce genomic instability events in a transgenic mouse model for Alzheimer's disease.
    Thomas P; Wang YJ; Zhong JH; Kosaraju S; O'Callaghan NJ; Zhou XF; Fenech M
    Mutat Res; 2009 Feb; 661(1-2):25-34. PubMed ID: 19027755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CHF5074, a novel gamma-secretase modulator, restores hippocampal neurogenesis potential and reverses contextual memory deficit in a transgenic mouse model of Alzheimer's disease.
    Imbimbo BP; Giardino L; Sivilia S; Giuliani A; Gusciglio M; Pietrini V; Del Giudice E; D'Arrigo A; Leon A; Villetti G; Calzà L
    J Alzheimers Dis; 2010; 20(1):159-73. PubMed ID: 20164581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interrelations and circadian changes of electroencephalogram frequencies under baseline conditions and constant sleep pressure in the rat.
    Yasenkov R; Deboer T
    Neuroscience; 2011 Apr; 180():212-21. PubMed ID: 21303684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic allopregnanolone treatment accelerates Alzheimer's disease development in AβPP(Swe)PSEN1(ΔE9) mice.
    Bengtsson SK; Johansson M; Bäckström T; Wang M
    J Alzheimers Dis; 2012; 31(1):71-84. PubMed ID: 22495347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.